Related Experiment Video
Updated: Aug 7, 2026
08:52
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Campylobacter vaccine development:a key to controlling enteric diseases
1Antex Biologics, 300 Professional Drive, Gaithersburg, MD 20879, USA. rwalker@antexbio.com
Expert Opinion on Investigational Drugs
|July 5, 2005
Summary
A new inactivated whole cell Campylobacter vaccine (CWC) shows promise for preventing Campylobacter jejuni infections, a leading cause of diarrheal disease globally. Clinical trials indicate the CWC vaccine is safe and elicits a strong immune response in humans.
Area of Science:
- Microbiology
- Immunology
- Vaccinology
Background:
- Campylobacter jejuni is a primary global cause of diarrheal disease, with current control methods being insufficient.
- Vaccination is the most promising strategy for disease control, as natural infection confers immunity.
- Conserved antigens across serotypes suggest a monovalent vaccine approach is feasible.
Purpose of the Study:
- To develop and evaluate an effective vaccine against Campylobacter jejuni infections.
- To overcome challenges in developing recombinant Campylobacter vaccines by exploring whole cell approaches.
- To assess the safety and immunogenicity of an inactivated whole cell Campylobacter vaccine (CWC) in preclinical and clinical settings.
Main Methods:
- Development of an inactivated Campylobacter whole cell (CWC) vaccine utilizing patented nutriment signal transduction (NST) technology.
- Evaluation of vaccine safety, immunogenicity, and efficacy in preclinical models.
- Phase I and Phase II clinical trials to assess safety and immunogenicity in human volunteers, with oral administration and adjuvant inclusion.
Main Results:
- The inactivated CWC vaccine demonstrated safety, immunogenicity, and protection in preclinical models.
- Inclusion of a mucosal adjuvant enhanced the immunological response.
- Phase I and II clinical trials confirmed the vaccine's safety and immunogenicity in humans.
Conclusions:
- The inactivated whole cell Campylobacter vaccine (CWC) is a safe and immunogenic candidate for preventing C. jejuni infections.
- The vaccine development platform is adaptable for creating vaccines against other mucosal pathogens.
- Further development and application of this CWC vaccine strategy hold significant public health potential.
Related Concept Videos
01:51Vaccinations
Overview
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:18Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
01:24Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
01:17Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...